ECOG- Frequently Asked Questions about the Thalidomide Non-Small Lung Cancer Study (E3598)

Follow the links below to view a handout answering frequently asked questions about the ECOG Thalidomide Non-Small Lung Cancer Study (E3598). This is a "Phase III Trial of Carboplatin, Paclitaxel and Thoracic Radiotherapy, with or without Thalidomide, in Patients with Stage III Non-Small Cell Lung Cancer ".

Frequently Asked Questions about the Thalidomide Non-Small Lung Cancer Study

The document is in Adobe Acrobat format. If you do not already have Adobe Acrobat Reader running on your computer you can download this software free of charge from the Adobe web site.

Next topic